// App-Quantinova.ai

S202 : TRANSFUSION INDEPENDENCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING MOMELOTINIB

Researchers

Presenter

  • Ruben Mesa

Principal Investigators

  • Aaron Gerds

  • Vikas Gupta

  • John Catalano

  • Francisco Cervantes

  • Timothy Devos

  • Marek Hus

  • Jean-Jacques Kiladjian

  • Ewa Lech-Maranda

  • Donal McLornan

  • Jeanne Palmer

  • Uwe Platzbecker

  • Jacek Trelinski

  • Kazuya Shimoda

  • Rafe Donahue

  • Bryan Strouse

  • Mark Kowalski

  • Srdan Verstovsek

Medical Centers

  • Cleveland Clinic Department of Hematology and Medical Oncology,Avon,United States

  • Hematology,University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven,Leuven,Belgique

  • Leipzig University, Leipzig, Germany

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • 8Mayo Clinic Hospital Phoenix AZ United States

  • Washington University, St. Louis, Missouri, United States

  • University of Miyazaki, Miyazaki, Japan

  • Sierra Oncology Inc., Vancouver, BC, Canada

  • Monash University &amp

  • Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin,Lublin,Polonia

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

  • UT Health San Antonio Cancer Center, San Antonio, TX

  • Aphp Saint-Louis Hospital, Paris, France

  • Medical University of Lodz, Lodz, Poland

  • Rheumatology, Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Frankston Hospital, Frankston, Australia

Locations

  • United States

  • Belgium

  • Germany

  • Canada

  • Japan

  • Poland

  • France

  • Spain

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Momelotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved